| 1 |
Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women
Jorma A. Paavonen et al. · The Lancet
|
Jul 2009 |
1,663 |
| 2 |
Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial
Jorma A. Paavonen et al. · The Lancet
|
Jun 2007 |
1,320 |
| 3 |
Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial
Matti Lehtinen et al. · The Lancet Oncology
|
9 Nov 2011 |
708 |
| 4 |
Impact and Effectiveness of the Quadrivalent Human Papillomavirus Vaccine: A Systematic Review of 10 Years of Real-world Experience
Suzanne Marie Garland, Susanne K. Kjær, Nubia Muñóz et al. · Clinical Infectious Diseases
ReviewOpen access |
26 May 2016 |
501 |
| 5 |
Comparison of the Immunogenicity and Reactogenicity of a Prophylactic Quadrivalent Human Papillomavirus (Types 6, 11, 16, and 18) L1 Virus-Like Particle Vaccine in Male and Female Adolescents and Young Adult Women
Stan L. Block, Terry M. Nolan, Carlos A. Sattler et al. · PEDIATRICS
|
Nov 2006 |
486 |
| 6 |
Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine
Robert B. Belshe, William C. Gruber, Paul M. Mendelman et al. · The Journal of Pediatrics
|
Feb 2000 |
434 |
| 7 |
Correlates of Immune Protection Induced by Live, Attenuated, Cold‐Adapted, Trivalent, Intranasal Influenza Virus Vaccine
Robert B. Belshe, William C. Gruber, Paul M. Mendelman et al. · The Journal of Infectious Diseases
|
Mar 2000 |
414 |
| 8 |
Mycoplasma pneumoniae and Chlamydia pneumoniae in pediatric community-acquired pneumonia
Stan Block, JAMES A. HEDRICK, Margaret R. Hammerschlag et al. · The Pediatric Infectious Disease Journal
|
Jun 1995 |
344 |
| 9 |
Community-Wide Vaccination with the Heptavalent Pneumococcal Conjugate Significantly Alters the Microbiology of Acute Otitis Media
Stan L. Block, JAMES A. HEDRICK, Christopher J Harrison et al. · The Pediatric Infectious Disease Journal
|
Sep 2004 |
329 |
| 10 |
Safety and Persistent Immunogenicity of a Quadrivalent Human Papillomavirus Types 6, 11, 16, 18 L1 Virus-Like Particle Vaccine in Preadolescents and Adolescents
Keith S. Reisinger, Stan L. Block, Eduardo Cesar Lazcano-Ponce et al. · The Pediatric Infectious Disease Journal
|
27 Feb 2007 |
298 |
| 11 |
Penicillin-resistant Streptococcus pneumoniae in acute otitis media
Stan L. Block, Christopher J. Harrison, JAMES A. HEDRICK et al. · The Pediatric Infectious Disease Journal
|
Sep 1995 |
260 |
| 12 |
Zanamivir for treatment of symptomatic influenza A and B infection in children five to twelve years of age: a randomized controlled trial
JAMES A. HEDRICK, Asher Barzilai, Ulrich Behre et al. · The Pediatric Infectious Disease Journal
|
May 2000 |
246 |
| 13 |
Immunogenicity and Safety of 13-Valent Pneumococcal Conjugate Vaccine in Infants and Toddlers
Sylvia H. Yeh, Alejandra Gurtman, David C. Hurley et al. · PEDIATRICS
|
24 Aug 2010 |
238 |
| 14 |
Natural History of Progression of HPV Infection to Cervical Lesion or Clearance: Analysis of the Control Arm of the Large, Randomised PATRICIA Study
Unnop Jaisamrarn et al. · PLoS ONE
Open access |
19 Nov 2013 |
218 |
| 15 |
Immunogenicity of the 9-Valent HPV Vaccine Using 2-Dose Regimens in Girls and Boys vs a 3-Dose Regimen in Women
Ole‐Erik Iversen et al. · JAMA
|
28 Nov 2016 |
214 |
| 16 |
Safety and Immunogenicity of a 13-Valent Pneumococcal Conjugate Vaccine
Kristina A. Bryant, Stan L. Block, Sherryl A. Baker et al. · PEDIATRICS
|
30 Apr 2010 |
188 |
| 17 |
High prevalence of multidrug-resistant Streptococcus pneumoniae among children in a rural Kentucky community
Jeffrey S. Duchin, Robert F. Breiman, Ann Stuart Diamond et al. · The Pediatric Infectious Disease Journal
|
Sep 1995 |
165 |
| 18 |
Causative pathogens, antibiotic resistance and therapeutic considerations in acute otitis media
Stan L. Block · The Pediatric Infectious Disease Journal
|
Apr 1997 |
155 |
| 19 |
Shortened Antimicrobial Treatment for Acute Otitis Media in Young Children
Alejandro Hoberman, Jack L. Paradise, Howard E. Rockette et al. · New England Journal of Medicine
Open access |
21 Dec 2016 |
146 |
| 20 |
Efficacy of the human papillomavirus (HPV)‐16/18 AS04‐adjuvanted vaccine in women aged 15–25 years with and without serological evidence of previous exposure to HPV‐16/18
Anne Szarewski et al. · International Journal of Cancer
Open access |
19 Aug 2011 |
143 |
| 21 |
Safety and immunogenicity of a novel hexavalent group B streptococcus conjugate vaccine in healthy, non-pregnant adults: a phase 1/2, randomised, placebo-controlled, observer-blinded, dose-escalation trial
Judith Absalon, Nathan Segall, Stan L. Block et al. · The Lancet Infectious Diseases
Open access |
3 Sep 2020 |
139 |
| 22 |
Efficacy, Immunogenicity, and Safety of a Pentavalent Human-Bovine (WC3) Reassortant Rotavirus Vaccine at the End of Shelf Life
Stan L. Block, Timo Vesikari, Michelle G. Goveia et al. · PEDIATRICS
|
2007 |
138 |
| 23 |
Immunogenicity and Safety of a 9-Valent HPV Vaccine
Pierre Van Damme, Sven Eric Olsson, S. Block et al. · PEDIATRICS
Open access |
23 Jun 2015 |
135 |
| 24 |
An Overview of Quadrivalent Human Papillomavirus Vaccine Safety
Michelle D. Vichnin, Paolo Bonanni, Nicola P. Klein et al. · The Pediatric Infectious Disease Journal
Open access |
23 Jun 2015 |
127 |
| 25 |
Baloxavir Marboxil Single-dose Treatment in Influenza-infected Children
Jeffrey P. Baker, Stanley L. Block, Balpreet Matharu et al. · The Pediatric Infectious Disease Journal
Open access |
19 May 2020 |
124 |
| 26 |
Parents' decision-making regarding vaccinating their children against influenza: A web-based survey
Emuella M. Flood, Matthew D. Rousculp, Kellie J. Ryan et al. · Clinical Therapeutics
|
Aug 2010 |
123 |
| 27 |
Safety Profile of the 9-Valent HPV Vaccine: A Combined Analysis of 7 Phase III Clinical Trials
Edson Duarte Moreira et al. · PEDIATRICS
Open access |
15 Jul 2016 |
120 |
| 28 |
Differential control of ATGL-mediated lipid droplet degradation by CGI-58 and G0S2
Xin Lü, Xingyuan Yang, Jun Liu · Cell Cycle
Open access |
15 Jul 2010 |
117 |
| 29 |
Clinical Trial and Post-Licensure Safety Profile of a Prophylactic Human Papillomavirus (Types 6, 11, 16, and 18) L1 Virus-Like Particle Vaccine
Stan L. Block, Darron R. Brown, Archana Chatterjee et al. · The Pediatric Infectious Disease Journal
|
29 Jan 2010 |
116 |
| 30 |
Shedding and immunogenicity of live attenuated influenza vaccine virus in subjects 5–49 years of age
Stan L. Block, Ram Yogev, Frederick G. Hayden et al. · Vaccine
|
27 Jul 2008 |
108 |
| 31 |
Prior human papillomavirus‐16/18 AS04‐adjuvanted vaccination prevents recurrent high grade cervical intraepithelial neoplasia after definitive surgical therapy: Post‐hoc analysis from a randomized controlled trial
Suzanne Marie Garland et al. · International Journal of Cancer
Open access |
19 Aug 2016 |
105 |
| 32 |
Long-term Study of a Quadrivalent Human Papillomavirus Vaccine
Daron Ferris, Rudiwilai Samakoses, Stan L. Block et al. · PEDIATRICS
|
19 Aug 2014 |
104 |
| 33 |
Association of Proinflammatory Cytokine Gene Polymorphisms With Susceptibility to Otitis Media
Janak A. Patel, Sangeeta Nair, Krystal Revai et al. · PEDIATRICS
|
Dec 2006 |
95 |
| 34 |
Increasing Bacterial Resistance in Pediatric Acute Conjunctivitis (1997–1998)
Stan L. Block, JAMES A. HEDRICK, Ron Tyler et al. · Antimicrobial Agents and Chemotherapy
Open access |
Jun 2000 |
94 |
| 35 |
Safety, Effectiveness, and Pharmacokinetics of Crisaborole in Infants Aged 3 to < 24 Months with Mild-to-Moderate Atopic Dermatitis: A Phase IV Open-Label Study (CrisADe CARE 1)
Joel Schlessinger, Julie S. Shepard, Richard Gower et al. · American Journal of Clinical Dermatology
Open access |
24 Mar 2020 |
91 |
| 36 |
Tympanostomy Tubes or Medical Management for Recurrent Acute Otitis Media
Alejandro Hoberman et al. · New England Journal of Medicine
Open access |
12 May 2021 |
90 |
| 37 |
Quadrivalent Meningococcal Vaccination of Adults: Phase III Comparison of an Investigational Conjugate Vaccine, MenACWY-CRM, with the Licensed Vaccine, Menactra
Keith S. Reisinger, Roger P. Baxter, Stanley L. Block et al. · Clinical and Vaccine Immunology
Open access |
8 Oct 2009 |
87 |
| 38 |
4-Valent Human Papillomavirus (4vHPV) Vaccine in Preadolescents and Adolescents After 10 Years
Daron G. Ferris, Rudiwilai Samakoses, Stanley L. Block et al. · PEDIATRICS
|
22 Nov 2017 |
76 |
| 39 |
Immunogenicity and Safety of a Quadrivalent Live Attenuated Influenza Vaccine in Children
Stan L. Block, Judith Falloon, Jeffrey A. Hirschfield et al. · The Pediatric Infectious Disease Journal
|
30 Mar 2012 |
75 |
| 40 |
Acellular Pertussis Vaccine Booster Combined With Diphtheria and Tetanus Toxoids for Adolescents
Michael E. Pichichero, Mark M. Blatter, William A. II Kennedy et al. · PEDIATRICS
|
Apr 2006 |
73 |
| 41 |
The Efficacy of Live Attenuated Influenza Vaccine Against Influenza-associated Acute Otitis Media in Children
Stan L. Block, Terho Heikkinen, Seth L Toback et al. · The Pediatric Infectious Disease Journal
|
8 Oct 2010 |
73 |
| 42 |
Subunit Influenza Vaccines Produced from Cell Culture or in Embryonated Chicken Eggs: Comparison of Safety, Reactogenicity, and Immunogenicity
Keith S. Reisinger, Stanley L. Block, Allen Izu et al. · The Journal of Infectious Diseases
|
12 Aug 2009 |
71 |
| 43 |
Evaluation of the safety, reactogenicity and immunogenicity of FluBlok® trivalent recombinant baculovirus-expressed hemagglutinin influenza vaccine administered intramuscularly to healthy children aged 6–59 months
James C. King, Manon M. J. Cox, Keith S. Reisinger et al. · Vaccine
|
28 Aug 2009 |
69 |
| 44 |
Chlamydia pneumoniae in acute otitis media
Stan L. Block, Margaret R. Hammerschlag, JAMES A. HEDRICK et al. · The Pediatric Infectious Disease Journal
|
Sep 1997 |
66 |
| 45 |
A randomized, double-blind noninferiority study of quadrivalent live attenuated influenza vaccine in adults
Stan L. Block, Tingting Yi, Eric A. Sheldon et al. · Vaccine
|
12 Oct 2011 |
64 |
| 46 |
Efficacy of amoxicillin/clavulanate for acute otitis media: relation to Streptococcus pneumoniae susceptibility
Alejandro Hoberman, Jack L. Paradise, Stan Block et al. · The Pediatric Infectious Disease Journal
|
Oct 1996 |
63 |
| 47 |
Long-term immunogenicity, effectiveness, and safety of nine-valent human papillomavirus vaccine in girls and boys 9 to 15 years of age: Interim analysis after 8 years of follow-up
Sven-Eric Olsson, Jaime Alberto Restrepo, Julio Cesar Reina et al. · Papillomavirus Research
Open access |
10 Jul 2020 |
61 |
| 48 |
Safety, Tolerability, and Immunogenicity of Gardasil Given Concomitantly With Menactra and Adacel
Keith S. Reisinger, Stan L. Block, Michelle D. Collins-Ogle et al. · PEDIATRICS
|
4 May 2010 |
61 |
| 49 |
Adhesin Expression in Matched Nasopharyngeal and Middle Ear Isolates of Nontypeable Haemophilus influenzae from Children with Acute Otitis Media
Graham P. Krasan, David Cutter, Stan L. Block et al. · Infection and Immunity
Open access |
1999 |
58 |
| 50 |
A comparative evaluation of two investigational meningococcal ABCWY vaccine formulations: Results of a phase 2 randomized, controlled trial
Stan L. Block, Leszek Szenborn, Wendy Daly et al. · Vaccine
|
22 Mar 2015 |
58 |